CHIESI PHARMACEUTICALS PRIVATE LIMITED

CHIESI PHARMACEUTICALS PRIVATE LIMITED in Pakistan operates as a pharmaceutical company with local manufacturing and packaging capabilities, representing its global manufacturing parent company. It is not solely a trader.

CHIESI PHARMACEUTICALS PRIVATE LIMITED Enterprise Introduction

CHIESI PHARMACEUTICALS PRIVATE LIMITED is the Pakistani subsidiary of Chiesi Farmaceutici S.p.A., a leading international research-focused pharmaceutical group headquartered in Parma, Italy. The company is dedicated to improving the quality of human life by developing and marketing innovative therapeutic solutions.

In Pakistan, CHIESI PHARMACEUTICALS PRIVATE LIMITED is primarily involved in the marketing, sales, and distribution of a wide range of Chiesi products. These products span critical therapeutic areas including respiratory care, neonatology, and rare diseases. The company also oversees local manufacturing, secondary packaging, and final assembly operations to ensure the timely and efficient supply of medicines to the Pakistani market, adhering to stringent international quality standards.

With a strong commitment to scientific research, ethical practices, and patient well-being, CHIESI PHARMACEUTICALS PRIVATE LIMITED strives to make a significant contribution to the healthcare landscape of Pakistan, ensuring that innovative and high-quality medicines are accessible to patients and healthcare professionals across the nation.

Chiesi Pharmaceuticals Private Limited in Pakistan manufactures or sells products primarily in the following therapeutic areas:

Respiratory Care

Neonatology

Rare Diseases

Specific products typically manufactured or marketed by Chiesi globally, and likely available in Pakistan, include:

Respiratory Products

Foster (used for asthma and chronic obstructive pulmonary disease, COPD)

Trimbow (used for chronic obstructive pulmonary disease, COPD)

Clenil Modulite (used for asthma)

Neonatal Products

Curosurf (used for respiratory distress syndrome in premature infants)

Products for Rare Diseases

Lamzede (used for alpha-mannosidosis)

Holoclar (used for moderate to severe limbal stem cell deficiency)